文献速递母胎医学

肌醇治疗代谢综合征妊娠小鼠后其子代血管与代谢表型的研究

Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols.
PubMed 文献 · Am J Obstet Gynecol · 2018-12-03

本研究让患代谢综合征的雌性eNOS+/-小鼠妊娠期随机接受肌醇混合物(MI/DCI 7.2/0.18 mg/mL)或水安慰剂至分娩,评估子代血管与代谢表型。结果显示母体肌醇补充改善子代糖耐量、收缩压及血管反应,且对宫内环境异常的子代获益更明显,对遗传因素所致者获益较少。

要点

  • 母体肌醇补充改善eNOS+/-和WT子代糖耐量,P值分别为.03和.05。
  • 肌醇降低WT子代收缩压至110±10 mm Hg(P=.01),eNOS+/-子代未降低。
  • 肌醇改善两种子代乙酰胆碱血管舒张(P=.01和P=.03),对硝普钠反应无差异。

核心结论

  • 母体肌醇补充改善代谢综合征母鼠所产成年eNOS+/-和WT子代的糖耐量、收缩压及血管反应。
  • WT子代血管表型类似eNOS+/-子代,且对肌醇治疗反应更好,作者认为肌醇获益在宫内环境因素暴露的子代更明显、在遗传因素所致者较少。

研究设计与样本

  • 雌性eNOS+/-小鼠喂高脂饮食表现代谢综合征表型,与野生型雄鼠交配。
  • 妊娠第1天随机分配接受肌醇混合物(MI/DCI:7.2/0.18 mg/mL)或水安慰剂至分娩。
  • 子代在9-10周龄行葡萄糖耐量试验和收缩压测量,随后处死取颈动脉评估血管反应。

主要发现

  • 糖耐量试验显示eNOS+/-INOs子代血糖低于未治疗子代(P=.03),WT-INOs子代亦低于未治疗子代(P=.05)。
  • 收缩压在eNOS+/-子代高于WT子代(169±7 vs 142±9 mm Hg,P=.04),肌醇治疗降低WT-INOs子代收缩压(110±10 mm Hg,P=.01),但未降低eNOS+/-INOs子代。
  • 去氧肾上腺素最大收缩反应在eNOS+/-子代较高,肌醇治疗组降低(eNOS+/- 123±7 vs eNOS+/-INOs 82±11 mm Hg,P=.007),WT子代治疗与否无差异(WT 92±4 vs WT-INOs 75±7)。
  • L-NAME反应在eNOS+/-INOs和WT-INOs子代较未治疗子代降低。
  • 乙酰胆碱血管舒张在eNOS+/-和WT子代受损,母体肌醇治疗改善两种子代血管舒张(P=.01和P=.03),对硝普钠反应无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inositols (INOs) supplementation during pregnancy, specifically the combination of myo-inositol (MI) and D-chiro-inositol (DCI), has been reported to improve vascular parameters in women with gestational diabetes mellitus. We demonstrated previously that offspring born to pregnant mice lacking the endothelial nitric oxide synthase (eNOS+/-) gene have hypertension (HTN) as adults and, when fed a high-fat diet (HFD), develop a metabolic syndrome (MS) phenotype. OBJECTIVE: Our aim was to evaluate whether INOs treatment in pregnancy complicated by MS improves the vascular and metabolic profile in mice offspring programmed in utero to develop HTN and MS. MATERIALS AND METHODS: Heterozygous eNOS+/- mice fed an HFD manifest a MS phenotype. Female eNOS+/- mice with MS were bred with a wild-type (WT) male. On gestational day 1, pregnant females were randomly allocated to receive either a mixture of INOs (MI/DCI: 7.2/0.18 mg/mL) or water as placebo until delivery. The female offspring obtained were genotyped and categorized as: WT (genetically normal, with eNOS gene) and eNOS+/- offspring (genetically modified, heterozygous for eNOS gene). Both offspring developed in an abnormal uterine environment due to maternal MS. At 9-10 weeks of age, the offspring underwent a glucose tolerance test (GTT) and systolic blood pressure (SBP) measurement. The mice were then sacrificed, and the carotid arteries were isolated for evaluation of vascular responses. Responses to phenylephrine (PE), in the presence and absence of a nonspecific nitric oxide inhibitor (N-nitro-L-arginine methyl ester [L-NAME]), the vasodilator acetylcholine (ACh), and sodium nitroprusside (SNP) were assessed. RESULTS: The GTT showed lower glucose levels in both eNOS+/-INOs (P = .03) and WT-INOs (P = .05) offspring born to MS dams on INOs supplementation compared to offspring born to untreated dams. SBP was higher in eNOS+/- offspring compared to WT (169 ± 7 vs 142 ± 9 mm Hg, respectively, P = .04) and INOs treatment decreased SBP in WT-INOs (110 ± 10 mm Hg, P = .01) but not in eNOS+/-INOs offspring. Maximal (%Max) contractile response to PE was higher in eNOS+/- offspring born to MS dams and was decreased in those born to MS dams treated with INOs (%Max, eNOS+/-, 123 ± 7 vs eNOS+/-INOs, 82 ± 11 mm Hg, P = .007). No differences were seen in PE contractile responses in WT offspring born to MS dams treated or not treated with INOs (WT, 92 ± 4 vs WT-INOs, 75 ± 7). The L-NAME response was decreased in eNOS+/-INOs and WT-INOs offspring compared to untreated ones. The ACh vasorelaxation was impaired in eNOS+/- and WT offspring born to MS dams, and maternal INOs treatment improved offspring vascular relaxation in both offspring (P = .01 and P = .03, respectively). No differences were seen in response to SNP. CONCLUSION: Inositols supplementation improved glucose tolerance, SBP, and vascular responses in adult eNOS+/- and WT offspring born to dams with MS. Interestingly, WT born to MS dams show an altered vascular profile similar to eNOS+/- offspring and exhibit an improved response to INOs treatment. Our findings suggest that the benefits of INOs treatment are more pronounced in offspring exposed to environmental factors in utero, and less likely in those due to genetic factors.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Longo M, Alrais M, Tamayo EH, et al. Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols. Am J Obstet Gynecol. 2018. PMID: 30521799. doi:10.1016/j.ajog.2018.11.1101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。